About Smartox Biotechnology
The Smartox group is specialized in peptide science.
Smartox Biotechnology is a preclinical-stage company specialized in identifying and developing therapeutic peptides coming from animal venoms. The company has developed a unique discovery platform and patented a first compound in the field of Dravet Syndrome (WO2020260670A1).
SB-PEPTIDE is a CDMO company specialized in peptide manufacturing. The company offers high-quality peptide synthesis services of any kinds of peptides (long, cyclic, conjugated, libraries…) as well as a unique 10 days express synthesis service.
- Mr. Rémy Béroud, CEO
- Mr. Aurélien Claeyssen, Head of marketing & sales
- Dr. Michel De Waard, Scientific consultant
Scientific advisory board
- Michel De Waard, PhD
- Michel Lazdunski, Pr
- Sylvie Diochot, PhD
- Jean-Marc Sabatier, PhD
- Philippe Bullet, PhD
- Ahcene Boumendjel, Pr